Abstract
Bleomycin hydrolase (BH), a cysteine protease from the papain superfamily, is considered to be a candidate for the β-secretase, which is presumably involved in the production of β-amyloid peptide. The G/G genotype of BH was identified as a significant risk factor for the development of Alzheimer's disease (AD) in subjects not carrying the apolipoprotein E ε4 allele (apoE-ε4). However, this finding was recently challenged. We studied this polymorphism in a homogenous sample of German AD patients and controls. The over-representation of the G/G genotype in AD patients could be confirmed, however it was more pronounced in apoE-ε4 carriers. Additional studies should be undertaken to increase the confidence that the BH polymorphism is associated with AD and to explore the relationship between BH and apoE.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lendon CL, Ashall F, Goate AM . Exploring the etiology of Alzheimer disease using molecular genetics JAMA 1997; 277: 825–831
Cummings JL, Vinters HV, Cole GM, Khachaturian ZS . Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities Neurology 1998; 51: (Suppl 1) 2–17
Bromme D, Rossi AB, Smeekens SP, Anderson DC, Payan DG . Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization Biochemistry 1996; 35: 6706–6714
Montoya SE, Aston CE, DeKosky ST, Kamboh MI, Lazo JS, Ferrell RE . Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease Nat Genet 1998; 18: 211–212
Farrer LA, Abraham CR, Haines JL et al. Association between bleomycin hydrolase and Alzheimer's disease in Caucasians Ann Neurol 1998; 44: 808–811
Sackett DL . Bias in analytic research J Chronic Dis 1979; 32: 51–63
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 1984; 34: 939–944
Hixson JE, Vernier DT . Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J Lipid Res 1990; 31: 545–548
Montoya SE, Ferrell RE, Lazo JS . Genomic structure and genetic mapping of the human neutral cysteine protease bleomycin hydrolase Cancer Res 1997; 57: 4191–4195
Acknowledgements
Supported by the Deutsche Forschungsgemeinschaft (He 2318) and the BONFOR grants program of the Medical Faculty of the University of Bonn (AP 111/34).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Papassotiropoulos, A., Bagli, M., Jessen, F. et al. Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease. Mol Psychiatry 5, 213–215 (2000). https://doi.org/10.1038/sj.mp.4000656
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000656
Keywords
This article is cited by
-
Metabolism and neurotoxicity of homocysteine thiolactone in mice: protective role of bleomycin hydrolase
Amino Acids (2012)
-
Analysis of association between bleomycin hydrolase and apolipoprotein E polymorphism in Alzheimer’s disease
Neurological Sciences (2010)
-
Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder
Molecular Psychiatry (2002)